ASCYX | NRGEX | ASCYX / NRGEX | |
Total Expense Ratio | 0.86 | 0.03 | 2,867% |
Annual Report Gross Expense Ratio | 1.02 | 0.69 | 148% |
Fund Existence | 4 years | 4 years | - |
Gain YTD | 3.066 | -0.885 | -346% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 197M | 9.1B | 2% |
Annual Yield % from dividends | 0.00 | 0.53 | - |
Returns for 1 year | 6.52 | -1.80 | -362% |
Returns for 3 years | 23.64 | 10.22 | 231% |
Returns for 5 years | N/A | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PYPG | 15.78 | 0.07 | +0.44% |
Leverage Shares 2X Long PYPL Daily ETF | |||
ADME | 50.61 | 0.16 | +0.32% |
Aptus Drawdown Managed Equity ETF | |||
STRV | 42.70 | 0.12 | +0.29% |
Strive 500 ETF | |||
FMED | 24.39 | -0.20 | -0.81% |
Fidelity Disruptive Medicine ETF | |||
CRSH | 3.27 | -0.12 | -3.54% |
YieldMax Short TSLA Option Income Strategy ETF |